Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders
Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A maj...
Saved in:
Published in | Molecular psychiatry Vol. 11; no. 7; pp. 663 - 679 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.07.2006
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1359-4184 1476-5578 |
DOI | 10.1038/sj.mp.4001830 |
Cover
Abstract | Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders. |
---|---|
AbstractList | Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders. Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.Molecular Psychiatry (2006) 11, 663-679. doi:10.1038/sj.mp.4001830; published online 25 April 2006 Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders.Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control brains with low pH versus high pH and showed that 28% of genes in mitochondrial-related pathways meet criteria for differential expression. A majority of genes in the mitochondrial, chaperone and proteasome pathways of nuclear DNA-encoded gene expression were decreased with decreased brain pH, whereas a majority of genes in the apoptotic and reactive oxygen stress pathways showed an increased gene expression with a decreased brain pH. There was a significant increase in mitochondrial DNA copy number and mitochondrial DNA gene expression with increased agonal duration. To minimize effects of agonal-pH state on mood disorder comparisons, two classic approaches were used, removing all subjects with low pH and agonal factors from analysis, or grouping low and high pH as a separate variable. Three groups of potential candidate genes emerged that may be mood disorder related: (a) genes that showed no sensitivity to pH but were differentially expressed in bipolar disorder or major depressive disorder; (b) genes that were altered by agonal-pH in one direction but altered in mood disorder in the opposite direction to agonal-pH and (c) genes with agonal-pH sensitivity that displayed the same direction of changes in mood disorder. Genes from these categories such as NR4A1 and HSPA2 were confirmed with Q-PCR. The interpretation of postmortem brain studies involving broad mitochondrial gene expression and related pathway alterations must be monitored against the strong effect of agonal-pH state. Genes with the least sensitivity to agonal-pH could present a starting point for candidate gene search in neuropsychiatric disorders. |
Audience | Academic |
Author | Akil, H Walsh, D M Neal, C Myers, R Li, J Tomita, H Burmeister, M Speed, T Vawter, M P Shao, L Evans, S Choudary, P Bolstad, B Meng, F Atz, M Jones, E G Bunney, W E Watson, S J |
AuthorAffiliation | 3 Biostatistics, University of California, Berkeley, CA, USA 2 Mental Health Research Institute, University of Michigan, Ann Arbor, MI, USA 1 Department of Psychiatry, University of California, Irvine, CA, USA 4 Stanford Human Genome Center, Stanford University, Palo Alto, CA, USA 6 University of Hawaii, John A. Burns School of Medicine, Honolulu, HI, USA 5 Center for Neuroscience, University of California, Davis, CA, USA |
AuthorAffiliation_xml | – name: 2 Mental Health Research Institute, University of Michigan, Ann Arbor, MI, USA – name: 3 Biostatistics, University of California, Berkeley, CA, USA – name: 1 Department of Psychiatry, University of California, Irvine, CA, USA – name: 4 Stanford Human Genome Center, Stanford University, Palo Alto, CA, USA – name: 5 Center for Neuroscience, University of California, Davis, CA, USA – name: 6 University of Hawaii, John A. Burns School of Medicine, Honolulu, HI, USA |
Author_xml | – sequence: 1 givenname: M P surname: Vawter fullname: Vawter, M P email: mvawter@uci.edu organization: Department of Psychiatry, University of California – sequence: 2 givenname: H surname: Tomita fullname: Tomita, H organization: Department of Psychiatry, University of California – sequence: 3 givenname: F surname: Meng fullname: Meng, F organization: Mental Health Research Institute, University of Michigan – sequence: 4 givenname: B surname: Bolstad fullname: Bolstad, B organization: Biostatistics, University of California – sequence: 5 givenname: J surname: Li fullname: Li, J organization: Stanford Human Genome Center, Stanford University – sequence: 6 givenname: S surname: Evans fullname: Evans, S organization: Mental Health Research Institute, University of Michigan – sequence: 7 givenname: P surname: Choudary fullname: Choudary, P organization: Center for Neuroscience, University of California – sequence: 8 givenname: M surname: Atz fullname: Atz, M organization: Department of Psychiatry, University of California – sequence: 9 givenname: L surname: Shao fullname: Shao, L organization: Department of Psychiatry, University of California – sequence: 10 givenname: C surname: Neal fullname: Neal, C organization: University of Hawaii, John A. Burns School of Medicine – sequence: 11 givenname: D M surname: Walsh fullname: Walsh, D M organization: Department of Psychiatry, University of California – sequence: 12 givenname: M surname: Burmeister fullname: Burmeister, M organization: Mental Health Research Institute, University of Michigan – sequence: 13 givenname: T surname: Speed fullname: Speed, T organization: Biostatistics, University of California – sequence: 14 givenname: R surname: Myers fullname: Myers, R organization: Stanford Human Genome Center, Stanford University – sequence: 15 givenname: E G surname: Jones fullname: Jones, E G organization: Center for Neuroscience, University of California – sequence: 16 givenname: S J surname: Watson fullname: Watson, S J organization: Mental Health Research Institute, University of Michigan – sequence: 17 givenname: H surname: Akil fullname: Akil, H organization: Mental Health Research Institute, University of Michigan – sequence: 18 givenname: W E surname: Bunney fullname: Bunney, W E organization: Department of Psychiatry, University of California |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17936369$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16636682$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1v1DAQxSNURD_gyBVZIOCUJU78yQGpqoAiFXGBs-U4k12vEjvY2Yr-952lC0urFvlgy_N7z57ROy4OQgxQFM9ptaBVo97l9WKcFqyqqGqqR8URZVKUnEt1gOeG65JRxQ6L45zXyGCRPykOqRCNEKo-Kqavfo5uFUOXvB3KBIOdoSNLCEDg15QgZx8DcSsblpCJTUAyhOxnfwlkjsQuY0DddE7yjMr3xI_T4J2dUZVJHxNpk_WBdD7H1EHKT4vHvR0yPNvtJ8WPTx-_n52XF98-fzk7vSidaPhcgnSiqzqmOias67S0ddV2nEmlGHNOV5ZLK3tBWaN0DUBpzUUr29bKugVeNyfFhxvfadOO0DkIc7KDmZIfbboy0XpzuxL8yizjpWkqrThXaPB2Z5Dizw3k2Yw-OxgGGyBuspFcN1RxKZF8819SIKWVFgi-ugOu4ybh_LKpBeOS11Rt7V4-SNXYJlOc7q2WdgDjQx-xCbd915xSpTgTmldILe6hcHUweodB6j3e3xK8-Hdqf8f1JzAIvN4BNjs79MkG5_Oek7pBUiNX3nAuxZwT9HukMtvgmrw242R2wUW-ucM7P_9OEf7YDw-qdv1ldMeApv2o7hdcA5CNANs |
CitedBy_id | crossref_primary_10_1016_j_neubiorev_2022_104892 crossref_primary_10_1016_j_biopsych_2007_11_010 crossref_primary_10_1016_j_biopsych_2008_11_010 crossref_primary_10_1371_journal_pone_0190456 crossref_primary_10_1007_s12640_016_9621_9 crossref_primary_10_1016_j_schres_2014_08_026 crossref_primary_10_1038_s41398_017_0048_8 crossref_primary_10_1016_j_brainresbull_2011_07_018 crossref_primary_10_1002_pmic_200900287 crossref_primary_10_3390_biomedicines9050522 crossref_primary_10_1016_j_schres_2020_09_003 crossref_primary_10_1016_j_bbi_2021_09_003 crossref_primary_10_1196_annals_1432_027 crossref_primary_10_1186_1755_8794_2_62 crossref_primary_10_1016_j_biopsych_2017_09_010 crossref_primary_10_1016_j_ceca_2007_11_005 crossref_primary_10_1016_j_pnpbp_2013_09_002 crossref_primary_10_1038_sj_mp_4001969 crossref_primary_10_1038_mp_2009_18 crossref_primary_10_1038_tp_2016_224 crossref_primary_10_1016_j_brainres_2010_01_006 crossref_primary_10_1111_j_1440_1819_2010_02178_x crossref_primary_10_1038_mp_2016_65 crossref_primary_10_1007_s00401_011_0828_9 crossref_primary_10_1016_j_schres_2011_06_024 crossref_primary_10_1371_journal_pone_0053855 crossref_primary_10_1038_sj_mp_4002095 crossref_primary_10_1038_sj_npp_1301671 crossref_primary_10_1002_ajmg_b_32134 crossref_primary_10_1016_j_ncl_2015_08_011 crossref_primary_10_1111_j_1399_5618_2008_00607_x crossref_primary_10_1016_j_ajp_2020_102193 crossref_primary_10_1038_mp_2009_117 crossref_primary_10_1016_j_pnpbp_2015_06_012 crossref_primary_10_7554_eLife_89376 crossref_primary_10_1016_j_nbd_2011_03_001 crossref_primary_10_1155_2014_452891 crossref_primary_10_1016_j_biopsych_2009_12_011 crossref_primary_10_1016_j_neures_2008_12_004 crossref_primary_10_1002_ajmg_b_30481 crossref_primary_10_1080_07853890801923753 crossref_primary_10_1016_j_psychres_2024_115928 crossref_primary_10_1016_j_nbd_2010_11_004 crossref_primary_10_1016_j_neuropharm_2011_07_023 crossref_primary_10_1111_j_1365_2990_2012_01285_x crossref_primary_10_1038_jhg_2009_93 crossref_primary_10_1038_mp_2014_157 crossref_primary_10_1038_sj_mp_4001875 crossref_primary_10_1016_j_neubiorev_2017_01_014 crossref_primary_10_1038_npp_2013_239 crossref_primary_10_1136_jech_2013_202430 crossref_primary_10_1016_j_biopsych_2010_09_035 crossref_primary_10_1016_j_neubiorev_2016_06_040 crossref_primary_10_1371_journal_pone_0049183 crossref_primary_10_1002_ajmg_b_30707 crossref_primary_10_1038_tp_2014_9 crossref_primary_10_1016_j_jneumeth_2007_03_022 crossref_primary_10_7554_eLife_89376_3 crossref_primary_10_1007_s11011_013_9473_4 crossref_primary_10_1016_j_csbj_2022_08_037 crossref_primary_10_1016_j_jpsychires_2023_01_005 crossref_primary_10_7554_eLife_31126 crossref_primary_10_1016_j_euroneuro_2024_10_012 crossref_primary_10_1007_s00702_009_0319_5 crossref_primary_10_1016_j_neurobiolaging_2011_04_010 crossref_primary_10_1016_j_biopsych_2014_12_025 crossref_primary_10_1016_j_jpsychires_2020_11_016 crossref_primary_10_1016_j_pbb_2011_01_017 crossref_primary_10_1038_s41537_019_0089_5 crossref_primary_10_1002_cne_24543 crossref_primary_10_3390_ijms22168358 crossref_primary_10_1038_mp_2014_63 crossref_primary_10_1111_pcn_12163 crossref_primary_10_1186_2045_5380_2_10 crossref_primary_10_1038_s41598_017_03599_8 crossref_primary_10_1002_pmic_200900015 crossref_primary_10_1007_s00702_006_0581_8 crossref_primary_10_1155_2015_408136 crossref_primary_10_3109_00048670903393662 crossref_primary_10_1016_j_nbd_2011_01_025 crossref_primary_10_1016_j_biopsych_2011_03_038 crossref_primary_10_1007_s00401_009_0482_7 crossref_primary_10_1080_15622975_2020_1755450 crossref_primary_10_1177_070674370705201203 crossref_primary_10_1016_j_pneurobio_2009_09_001 crossref_primary_10_1016_j_tins_2008_07_007 crossref_primary_10_1016_j_mcn_2020_103555 crossref_primary_10_1016_j_schres_2022_08_027 crossref_primary_10_1016_j_jpsychires_2015_10_015 crossref_primary_10_1089_omi_2006_10_444 |
Cites_doi | 10.1001/archpsyc.61.5.450 10.1007/BF01251916 10.1016/j.biopsych.2003.10.016 10.1046/j.1365-2141.2003.04601.x 10.1001/archpsyc.61.3.300 10.1073/pnas.0406788101 10.1002/jnr.10631 10.1016/S0197-4580(99)00092-5 10.1016/0041-008X(88)90031-2 10.1016/S0891-0618(01)00135-1 10.1146/annurev.bi.65.070196.003023 10.1038/nm972 10.1034/j.1399-5618.2000.020305.x 10.1038/sj.mp.4001511 10.1016/j.biopsych.2005.03.031 10.1038/sj.npp.1300400 10.1073/pnas.0630589100 10.2144/04364ST03 10.1016/S0361-9230(01)00744-4 10.1016/S0920-9964(01)00377-2 10.1016/S0006-3223(03)00114-8 10.1111/j.1471-4159.2004.02570.x 10.1074/jbc.M106583200 10.1016/S0006-3223(97)00012-7 10.1073/pnas.95.22.13290 10.1016/0006-2952(86)90108-5 10.1016/S0165-0270(97)00115-5 10.1016/S0006-3223(00)00988-4 10.1016/j.molbrainres.2004.09.010 10.1186/gb-2003-4-10-r70 10.1038/ng1291 10.1586/14737159.3.5.635 10.1038/sj.npp.1300335 10.1016/j.jneumeth.2004.04.002 10.1038/sj.npp.1300337 10.1001/archpsyc.58.6.545 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.0.CO;2-Q 10.1007/s004010100392 10.1093/nar/gni179 10.1007/BF02834269 10.1111/j.1399-5618.2005.00184.x 10.1002/ajmg.b.20041 10.1073/pnas.081071198 10.1016/j.biopsych.2003.10.013 10.1073/pnas.0403649101 10.1016/0165-0327(93)90097-4 10.1176/ajp.154.7.976 10.1101/gr.1982804 10.1016/S0006-291X(03)00473-X 10.1046/j.1471-4159.2002.01263.x 10.1016/S0006-3223(99)00041-4 10.1023/B:NERE.0000023611.99452.47 10.1042/BJ20040469 10.1016/S0165-0327(99)00173-1 10.1016/S0304-3940(02)01334-4 10.1038/sj.mp.4001758 10.1111/j.1440-1819.2004.01197.x 10.1523/JNEUROSCI.22-07-02718.2002 10.1016/S0361-9230(01)00522-6 10.1074/jbc.M006807200 10.1073/pnas.242716699 10.1002/cne.903590310 10.1016/0165-0327(95)00050-X 10.1038/sj.mp.4001565 10.1023/A:1006912010550 10.1016/S0022-3476(87)80157-9 10.1038/ng1235 10.1093/brain/awf149 10.1016/j.biopsych.2004.11.041 10.1093/cercor/12.4.386 10.1016/S0006-3223(00)00978-1 10.1093/hmg/ddi022 10.1038/sj.mp.4001437 10.1097/01.ASN.0000095481.24091.C9 10.1016/0925-4927(94)90010-8 10.1046/j.1471-4159.2001.00628.x 10.1093/hmg/ddh065 10.1016/0304-3940(95)12102-A 10.1186/gb-2003-4-5-p3 10.1034/j.1399-5618.2002.40201.x |
ContentType | Journal Article |
Copyright | Springer Nature Limited 2006 2006 INIST-CNRS COPYRIGHT 2006 Nature Publishing Group Copyright Nature Publishing Group Jul 2006 Nature Publishing Group 2006. 2006 Nature Publishing Group All rights reserved 2006 |
Copyright_xml | – notice: Springer Nature Limited 2006 – notice: 2006 INIST-CNRS – notice: COPYRIGHT 2006 Nature Publishing Group – notice: Copyright Nature Publishing Group Jul 2006 – notice: Nature Publishing Group 2006. – notice: 2006 Nature Publishing Group All rights reserved 2006 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1038/sj.mp.4001830 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni) Medical Database Psychology Collection Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Psychology Neurosciences Abstracts ProQuest One Psychology MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1476-5578 |
EndPage | 679 |
ExternalDocumentID | PMC3098558 1067213431 A188546950 16636682 17936369 10_1038_sj_mp_4001830 |
Genre | Comparative Study Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIMH NIH HHS grantid: P50 MH60398 – fundername: NIMH NIH HHS grantid: P01 MH042251 – fundername: NIMH NIH HHS grantid: MH54844 – fundername: NIMH NIH HHS grantid: P50 MH060398 – fundername: NIMH NIH HHS grantid: R01 MH054844 – fundername: NIMH NIH HHS grantid: MH42251 |
GroupedDBID | --- -Q- 0R~ 123 29M 2WC 36B 39C 4.4 406 53G 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AANZL AASML AAYZH ABAKF ABAWZ ABBRH ABDBE ABDBF ABFSG ABIVO ABJNI ABLJU ABRTQ ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACUHS ACZOJ ADBBV AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ATHPR AXYYD AYFIA AZQEC B0M BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL EPS ESX F5P FDQFY FEDTE FERAY FIZPM FSGXE FYUFA GNUQQ HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR IPY ITC IWAJR JSO JZLTJ KQ8 M1P M2M M7P NQJWS O9- OK1 OVD P2P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PSYQQ Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UKHRP ~8M AAYXX CITATION 70F AACDK AATNV BAWUL FIGPU IQODW CGR CUY CVF ECM EIF NPM PMFND AEIIB 3V. 7TK 7XB 8FE 8FH 8FK K9. LK8 PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c635t-e7c6d0d48d46acd97a20bd5478844cc90a57a7f6143892ee11256b7bba72be523 |
IEDL.DBID | 7X7 |
ISSN | 1359-4184 |
IngestDate | Thu Aug 21 18:21:15 EDT 2025 Fri Sep 05 05:30:18 EDT 2025 Thu Sep 04 22:17:22 EDT 2025 Fri Jul 25 08:45:38 EDT 2025 Fri Jul 25 09:11:37 EDT 2025 Tue Jun 17 22:22:17 EDT 2025 Tue Jun 10 21:15:04 EDT 2025 Fri May 30 11:00:56 EDT 2025 Wed Apr 02 07:24:00 EDT 2025 Thu Apr 24 22:51:19 EDT 2025 Tue Jul 01 00:21:36 EDT 2025 Mon Jul 21 06:09:52 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | proteasome apoptosis recurrent major depressive disorder chaperone bipolar disorder I mitochondria Mood disorder Human Multicatalytic endopeptidase complex Relapse Enzyme Central nervous system Depression Bipolar disorder Gene expression Encephalon Peptidases Mitochondria pH Hydrolases Apoptosis |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c635t-e7c6d0d48d46acd97a20bd5478844cc90a57a7f6143892ee11256b7bba72be523 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 16636682 |
PQID | 221254851 |
PQPubID | 44096 |
PageCount | 17 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3098558 proquest_miscellaneous_759318577 proquest_miscellaneous_68579896 proquest_journals_2645752187 proquest_journals_221254851 gale_infotracmisc_A188546950 gale_infotracacademiconefile_A188546950 pubmed_primary_16636682 pascalfrancis_primary_17936369 crossref_primary_10_1038_sj_mp_4001830 crossref_citationtrail_10_1038_sj_mp_4001830 springer_journals_10_1038_sj_mp_4001830 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-07-01 |
PublicationDateYYYYMMDD | 2006-07-01 |
PublicationDate_xml | – month: 07 year: 2006 text: 2006-07-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Basingstoke – name: England – name: New York |
PublicationTitle | Molecular psychiatry |
PublicationTitleAbbrev | Mol Psychiatry |
PublicationTitleAlternate | Mol Psychiatry |
PublicationYear | 2006 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | S Melov (BF4001830_CR63) 1999; 20 J Liu (BF4001830_CR87) 2004; 90 RO Poyton (BF4001830_CR48) 1996; 65 A Rotig (BF4001830_CR49) 2003; 14 T Kato (BF4001830_CR58) 1996; 37 MP Vawter (BF4001830_CR46) 2000; 48 M Emamghoreishi (BF4001830_CR56) 1997; 154 TL Petryshen (BF4001830_CR6) 2003 A Traven (BF4001830_CR47) 2001; 276 CA Altar (BF4001830_CR14) 2005; 58 MP Vawter (BF4001830_CR20) 2002; 58 A Sequeira (BF4001830_CR7) 2003 SR Dager (BF4001830_CR54) 2004; 61 T Kato (BF4001830_CR59) 1997; 42 NL Johnston (BF4001830_CR28) 1997; 77 MP Vawter (BF4001830_CR42) 2004; 29 S Washizuka (BF4001830_CR68) 2005; 7 SA McCarroll (BF4001830_CR69) 2004; 36 D Cotter (BF4001830_CR74) 2001; 58 MM Ryan (BF4001830_CR34) 2004; 55 C Curti (BF4001830_CR80) 1999; 199 NA Gray (BF4001830_CR39) 2003; 64 AM Roberton (BF4001830_CR82) 1988; 93 JK Kane (BF4001830_CR85) 2004; 132 G Chana (BF4001830_CR78) 2003; 53 S Washizuka (BF4001830_CR67) 2003; 120B H Hamakawa (BF4001830_CR51) 2004; 58 DA Hosack (BF4001830_CR40) 2003; 4 T Kato (BF4001830_CR52) 1994; 55 D Ben-Shachar (BF4001830_CR88) 2002; 83 T Kato (BF4001830_CR60) 2000; 96 X Li (BF4001830_CR72) 2002; 4 K Eto (BF4001830_CR81) 1985; 39 MJ Wasserman (BF4001830_CR55) 2004; 29 K Iwamoto (BF4001830_CR22) 2004; 9 K Brodmann (BF4001830_CR31) 1909 C Bouras (BF4001830_CR75) 2001; 102 C Aston (BF4001830_CR4) 2005; 10 HK Manji (BF4001830_CR38) 2001; 35 MP Vawter (BF4001830_CR21) 2001; 55 F Xu (BF4001830_CR45) 2004; 382 ND Trinklein (BF4001830_CR70) 2004; 14 C Morin (BF4001830_CR50) 1993; 53 PJ Harrison (BF4001830_CR35) 1995; 200 E Sibille (BF4001830_CR9) 2004; 29 MP Vawter (BF4001830_CR33) 2004; 29 BH Robinson (BF4001830_CR25) 1987; 110 JA Hardy (BF4001830_CR27) 1985; 61 S Prabakaran (BF4001830_CR16) 2004; 9 SJ Huffaker (BF4001830_CR5) 2003 LF Jarskog (BF4001830_CR71) 2000; 48 JZ Li (BF4001830_CR26) 2004; 13 EC Weinbach (BF4001830_CR79) 1986; 35 G Dennis Jr (BF4001830_CR41) 2003; 4 CR Neal Jr (BF4001830_CR43) 2001; 22 G Rajkowska (BF4001830_CR77) 1999; 45 CD Chen (BF4001830_CR3) 2004; 10 P Wester (BF4001830_CR29) 1985; 3 L Dyrskjot (BF4001830_CR1) 2003; 3 C Konradi (BF4001830_CR11) 2004; 61 YB Bezchlibnyk (BF4001830_CR8) 2001; 79 FM Benes (BF4001830_CR44) 2006; 11 C Kakiuchi (BF4001830_CR66) 2003; 35 T Kato (BF4001830_CR65) 2003; 338 PE Coskun (BF4001830_CR61) 2003; 100 KM Holtz (BF4001830_CR83) 2003; 303 Y Hakak (BF4001830_CR19) 2001; 98 K Munakata (BF4001830_CR57) 2005; 57 D Cotter (BF4001830_CR73) 2002; 12 LW Jurata (BF4001830_CR12) 2004; 138 SJ Evans (BF4001830_CR13) 2004; 101 M Dai (BF4001830_CR37) 2005; 33 PJ Harrison (BF4001830_CR15) 2002; 125 FA Middleton (BF4001830_CR17) 2002; 22 T Kato (BF4001830_CR23) 2000; 2 K Iwamoto (BF4001830_CR10) 2005; 14 AM Rice (BF4001830_CR84) 2001; 276 BP Sokolov (BF4001830_CR18) 2003; 72 T Kato (BF4001830_CR64) 2001; 62 F Bosetti (BF4001830_CR86) 2002; 57 M Ueda (BF4001830_CR2) 2003; 123 PE Coskun (BF4001830_CR62) 2004; 101 BA Vogt (BF4001830_CR32) 1995; 359 D Ongur (BF4001830_CR76) 1998; 95 H Tomita (BF4001830_CR30) 2004; 55 T Kato (BF4001830_CR53) 1993; 27 VK Mootha (BF4001830_CR24) 2003; 100 CL Miller (BF4001830_CR36) 2004; 36 |
References_xml | – volume: 61 start-page: 450 issue: 5 year: 2004 ident: BF4001830_CR54 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.5.450 – volume: 61 start-page: 253 issue: 3–4 year: 1985 ident: BF4001830_CR27 publication-title: J Neural Transm doi: 10.1007/BF01251916 – volume: 55 start-page: 329 issue: 4 year: 2004 ident: BF4001830_CR34 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2003.10.016 – volume: 123 start-page: 288 issue: 2 year: 2003 ident: BF4001830_CR2 publication-title: Br J Haematol doi: 10.1046/j.1365-2141.2003.04601.x – volume: 61 start-page: 300 issue: 3 year: 2004 ident: BF4001830_CR11 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.3.300 – volume: 101 start-page: 15506 issue: 43 year: 2004 ident: BF4001830_CR13 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0406788101 – volume-title: Identification of altered gene pathways in prefrontal cortex and cerebellum of schizophrenia, bipolar disorder, and depression patients. Program Number 312.12, in Abstract Viewer/Itinerary Planner year: 2003 ident: BF4001830_CR6 – volume: 72 start-page: 756 issue: 6 year: 2003 ident: BF4001830_CR18 publication-title: J Neurosci Res doi: 10.1002/jnr.10631 – volume: 20 start-page: 565 issue: 5 year: 1999 ident: BF4001830_CR63 publication-title: Neurobiol Aging doi: 10.1016/S0197-4580(99)00092-5 – volume: 93 start-page: 118 issue: 1 year: 1988 ident: BF4001830_CR82 publication-title: Toxicol Appl Pharmacol doi: 10.1016/0041-008X(88)90031-2 – volume: 22 start-page: 219 issue: 4 year: 2001 ident: BF4001830_CR43 publication-title: J Chem Neuroanat doi: 10.1016/S0891-0618(01)00135-1 – volume: 65 start-page: 563 year: 1996 ident: BF4001830_CR48 publication-title: Annu Rev Biochem doi: 10.1146/annurev.bi.65.070196.003023 – volume: 10 start-page: 33 issue: 1 year: 2004 ident: BF4001830_CR3 publication-title: Nat Med doi: 10.1038/nm972 – volume: 2 start-page: 180 issue: 3 Part 1 year: 2000 ident: BF4001830_CR23 publication-title: Bipolar Disord doi: 10.1034/j.1399-5618.2000.020305.x – volume: 9 start-page: 684 issue: 7 year: 2004 ident: BF4001830_CR16 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001511 – volume-title: Gene expression changes in suicides with and without major depression. Program Number 640.2, in Abstract Viewer/ Itinerary Planner year: 2003 ident: BF4001830_CR7 – volume: 64 start-page: 3 issue: Suppl 5 year: 2003 ident: BF4001830_CR39 publication-title: J Clin Psychiatry – volume: 58 start-page: 85 issue: 2 year: 2005 ident: BF4001830_CR14 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.03.031 – volume: 29 start-page: 759 issue: 4 year: 2004 ident: BF4001830_CR55 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300400 – volume: 100 start-page: 2174 issue: 5 year: 2003 ident: BF4001830_CR61 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0630589100 – volume: 36 start-page: 628 issue: 4 year: 2004 ident: BF4001830_CR36 publication-title: Biotechniques doi: 10.2144/04364ST03 – volume: 57 start-page: 205 issue: 2 year: 2002 ident: BF4001830_CR86 publication-title: Brain Res Bull doi: 10.1016/S0361-9230(01)00744-4 – volume: 58 start-page: 11 issue: 1 year: 2002 ident: BF4001830_CR20 publication-title: Schizophr Res doi: 10.1016/S0920-9964(01)00377-2 – volume: 53 start-page: 1086 issue: 12 year: 2003 ident: BF4001830_CR78 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(03)00114-8 – volume: 90 start-page: 1050 issue: 5 year: 2004 ident: BF4001830_CR87 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2004.02570.x – volume: 35 start-page: 5 issue: 2 year: 2001 ident: BF4001830_CR38 publication-title: Psychopharmacol Bull – volume: 276 start-page: 42722 issue: 46 year: 2001 ident: BF4001830_CR84 publication-title: J Biol Chem doi: 10.1074/jbc.M106583200 – volume: 42 start-page: 871 issue: 10 year: 1997 ident: BF4001830_CR59 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(97)00012-7 – volume: 95 start-page: 13290 issue: 22 year: 1998 ident: BF4001830_CR76 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.22.13290 – volume: 35 start-page: 1445 issue: 9 year: 1986 ident: BF4001830_CR79 publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(86)90108-5 – volume: 53 start-page: 488 issue: 2 year: 1993 ident: BF4001830_CR50 publication-title: Am J Hum Genet – volume: 77 start-page: 83 issue: 1 year: 1997 ident: BF4001830_CR28 publication-title: J Neurosci Methods doi: 10.1016/S0165-0270(97)00115-5 – volume: 48 start-page: 641 issue: 7 year: 2000 ident: BF4001830_CR71 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(00)00988-4 – volume: 132 start-page: 181 issue: 2 year: 2004 ident: BF4001830_CR85 publication-title: Brain Res Mol Brain Res doi: 10.1016/j.molbrainres.2004.09.010 – volume: 4 start-page: R70 issue: 10 year: 2003 ident: BF4001830_CR40 publication-title: Genome Biol doi: 10.1186/gb-2003-4-10-r70 – volume: 36 start-page: 197 issue: 2 year: 2004 ident: BF4001830_CR69 publication-title: Nat Genet doi: 10.1038/ng1291 – volume: 3 start-page: 635 issue: 5 year: 2003 ident: BF4001830_CR1 publication-title: Expert Rev Mol Diagn doi: 10.1586/14737159.3.5.635 – volume: 29 start-page: 351 issue: 2 year: 2004 ident: BF4001830_CR9 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300335 – volume: 138 start-page: 173 issue: 1–2 year: 2004 ident: BF4001830_CR12 publication-title: J Neurosci Methods doi: 10.1016/j.jneumeth.2004.04.002 – volume: 29 start-page: 373 issue: 2 year: 2004 ident: BF4001830_CR33 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300337 – volume: 58 start-page: 545 issue: 6 year: 2001 ident: BF4001830_CR74 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.58.6.545 – volume: 96 start-page: 182 issue: 2 year: 2000 ident: BF4001830_CR60 publication-title: Am J Med Genet doi: 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.0.CO;2-Q – volume: 102 start-page: 373 issue: 4 year: 2001 ident: BF4001830_CR75 publication-title: Acta Neuropathol (Berlin) doi: 10.1007/s004010100392 – volume: 33 start-page: e175 issue: 20 year: 2005 ident: BF4001830_CR37 publication-title: Nucleic Acids Res doi: 10.1093/nar/gni179 – volume: 3 start-page: 169 issue: 3 year: 1985 ident: BF4001830_CR29 publication-title: Neurochem Pathol doi: 10.1007/BF02834269 – volume: 7 start-page: 146 issue: 2 year: 2005 ident: BF4001830_CR68 publication-title: Bipolar Disord doi: 10.1111/j.1399-5618.2005.00184.x – volume-title: Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues year: 1909 ident: BF4001830_CR31 – volume: 120B start-page: 72 issue: 1 year: 2003 ident: BF4001830_CR67 publication-title: Am J Med Genet doi: 10.1002/ajmg.b.20041 – volume: 98 start-page: 4746 issue: 8 year: 2001 ident: BF4001830_CR19 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.081071198 – volume: 55 start-page: 346 issue: 4 year: 2004 ident: BF4001830_CR30 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2003.10.013 – volume: 39 start-page: 289 issue: 4 year: 1985 ident: BF4001830_CR81 publication-title: Acta Med Okayama – volume: 101 start-page: 10726 issue: 29 year: 2004 ident: BF4001830_CR62 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0403649101 – volume: 27 start-page: 53 issue: 1 year: 1993 ident: BF4001830_CR53 publication-title: J Affect Disord doi: 10.1016/0165-0327(93)90097-4 – volume: 154 start-page: 976 issue: 7 year: 1997 ident: BF4001830_CR56 publication-title: Am J Psychiatry doi: 10.1176/ajp.154.7.976 – volume: 14 start-page: 62 issue: 1 year: 2004 ident: BF4001830_CR70 publication-title: Genome Res doi: 10.1101/gr.1982804 – volume: 303 start-page: 1058 issue: 4 year: 2003 ident: BF4001830_CR83 publication-title: Biochem Biophys Res Commun doi: 10.1016/S0006-291X(03)00473-X – volume: 83 start-page: 1241 issue: 6 year: 2002 ident: BF4001830_CR88 publication-title: J Neurochem doi: 10.1046/j.1471-4159.2002.01263.x – volume: 45 start-page: 1085 issue: 9 year: 1999 ident: BF4001830_CR77 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(99)00041-4 – volume-title: Large scale genechip analysis of post - mortem brains from schizophrenia and bipolar affective disorder patients. Program Number 312.16, in Abstract Viewer/ Itinerary Planner year: 2003 ident: BF4001830_CR5 – volume: 29 start-page: 1245 issue: 6 year: 2004 ident: BF4001830_CR42 publication-title: Neurochem Res doi: 10.1023/B:NERE.0000023611.99452.47 – volume: 382 start-page: 331 issue: Part 1 year: 2004 ident: BF4001830_CR45 publication-title: Biochem J doi: 10.1042/BJ20040469 – volume: 62 start-page: 151 issue: 3 year: 2001 ident: BF4001830_CR64 publication-title: J Affect Disord doi: 10.1016/S0165-0327(99)00173-1 – volume: 338 start-page: 21 issue: 1 year: 2003 ident: BF4001830_CR65 publication-title: Neurosci Lett doi: 10.1016/S0304-3940(02)01334-4 – volume: 11 start-page: 241 issue: 3 year: 2006 ident: BF4001830_CR44 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001758 – volume: 58 start-page: 82 issue: 1 year: 2004 ident: BF4001830_CR51 publication-title: Psychiatry Clin Neurosci doi: 10.1111/j.1440-1819.2004.01197.x – volume: 22 start-page: 2718 issue: 7 year: 2002 ident: BF4001830_CR17 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-07-02718.2002 – volume: 55 start-page: 641 issue: 5 year: 2001 ident: BF4001830_CR21 publication-title: Brain Res Bull doi: 10.1016/S0361-9230(01)00522-6 – volume: 276 start-page: 4020 issue: 6 year: 2001 ident: BF4001830_CR47 publication-title: J Biol Chem doi: 10.1074/jbc.M006807200 – volume: 100 start-page: 605 issue: 2 year: 2003 ident: BF4001830_CR24 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.242716699 – volume: 359 start-page: 490 issue: 3 year: 1995 ident: BF4001830_CR32 publication-title: J Comp Neurol doi: 10.1002/cne.903590310 – volume: 37 start-page: 67 issue: 2–3 year: 1996 ident: BF4001830_CR58 publication-title: J Affect Disord doi: 10.1016/0165-0327(95)00050-X – volume: 10 start-page: 309 issue: 3 year: 2005 ident: BF4001830_CR4 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001565 – volume: 199 start-page: 103 issue: 1–2 year: 1999 ident: BF4001830_CR80 publication-title: Mol Cell Biochem doi: 10.1023/A:1006912010550 – volume: 110 start-page: 216 issue: 2 year: 1987 ident: BF4001830_CR25 publication-title: J Pediatr doi: 10.1016/S0022-3476(87)80157-9 – volume: 35 start-page: 171 issue: 2 year: 2003 ident: BF4001830_CR66 publication-title: Nat Genet doi: 10.1038/ng1235 – volume: 125 start-page: 1428 issue: Part 7 year: 2002 ident: BF4001830_CR15 publication-title: Brain doi: 10.1093/brain/awf149 – volume: 57 start-page: 525 issue: 5 year: 2005 ident: BF4001830_CR57 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2004.11.041 – volume: 12 start-page: 386 issue: 4 year: 2002 ident: BF4001830_CR73 publication-title: Cereb Cortex doi: 10.1093/cercor/12.4.386 – volume: 48 start-page: 486 issue: 6 year: 2000 ident: BF4001830_CR46 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(00)00978-1 – volume: 14 start-page: 241 issue: 2 year: 2005 ident: BF4001830_CR10 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddi022 – volume: 9 start-page: 406 issue: 4 year: 2004 ident: BF4001830_CR22 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001437 – volume: 14 start-page: 2995 issue: 12 year: 2003 ident: BF4001830_CR49 publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000095481.24091.C9 – volume: 55 start-page: 41 issue: 1 year: 1994 ident: BF4001830_CR52 publication-title: Psychiatry Res doi: 10.1016/0925-4927(94)90010-8 – volume: 79 start-page: 826 issue: 4 year: 2001 ident: BF4001830_CR8 publication-title: J Neurochem doi: 10.1046/j.1471-4159.2001.00628.x – volume: 13 start-page: 609 issue: 6 year: 2004 ident: BF4001830_CR26 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddh065 – volume: 200 start-page: 151 issue: 3 year: 1995 ident: BF4001830_CR35 publication-title: Neurosci Lett doi: 10.1016/0304-3940(95)12102-A – volume: 4 start-page: P3 issue: 5 year: 2003 ident: BF4001830_CR41 publication-title: Genome Biol doi: 10.1186/gb-2003-4-5-p3 – volume: 4 start-page: 137 issue: 2 year: 2002 ident: BF4001830_CR72 publication-title: Bipolar Disord doi: 10.1034/j.1399-5618.2002.40201.x |
SSID | ssj0014765 |
Score | 2.2676115 |
Snippet | Mitochondrial defects in gene expression have been implicated in the pathophysiology of bipolar disorder and schizophrenia. We have now contrasted control... |
SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 663 |
SubjectTerms | Adult and adolescent clinical studies Antidepressive Agents - pharmacology Apoptosis Apoptosis - genetics Behavioral Sciences Biological and medical sciences Biological Psychology Bipolar disorder Bipolar Disorder - drug therapy Bipolar Disorder - genetics Bipolar Disorder - metabolism Bipolar Disorder - pathology Bipolar disorders Brain Brain - drug effects Brain - metabolism Brain - pathology Cerebellum - drug effects Cerebellum - metabolism Cerebellum - pathology Copy number Death Depression Depressive Disorder - genetics Depressive Disorder - metabolism Depressive Disorder - pathology DNA, Mitochondrial - genetics DNA, Mitochondrial - metabolism Emotional disorders Female Gene Dosage Gene expression Gene Expression Regulation - drug effects Gene Expression Regulation - physiology Gyrus Cinguli - drug effects Gyrus Cinguli - metabolism Gyrus Cinguli - pathology Humans Hydrogen-Ion Concentration In Situ Hybridization Lithium - pharmacology Male Medical sciences Medicine Medicine & Public Health Mental disorders Middle Aged Mitochondria - drug effects Mitochondria - metabolism Mitochondrial DNA Molecular Chaperones - biosynthesis Molecular Chaperones - genetics Mood Mood disorders Neoplasm Proteins - biosynthesis Neoplasm Proteins - genetics Nerve Tissue Proteins - biosynthesis Nerve Tissue Proteins - genetics Neurosciences Oligonucleotide Array Sequence Analysis original-article Oxidative Stress - genetics pH effects Pharmacotherapy Polymerase Chain Reaction Postmortem Changes Prefrontal Cortex - drug effects Prefrontal Cortex - metabolism Prefrontal Cortex - pathology Proteasome Endopeptidase Complex - metabolism Proteasomes Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry RNA, Messenger - biosynthesis RNA, Messenger - genetics Schizophrenia Selective Serotonin Reuptake Inhibitors - pharmacology Time Factors |
Title | Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders |
URI | https://link.springer.com/article/10.1038/sj.mp.4001830 https://www.ncbi.nlm.nih.gov/pubmed/16636682 https://www.proquest.com/docview/221254851 https://www.proquest.com/docview/2645752187 https://www.proquest.com/docview/68579896 https://www.proquest.com/docview/759318577 https://pubmed.ncbi.nlm.nih.gov/PMC3098558 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgExLShPhN2Ch-QPBCtjTxT17QQJsqpE0IMalvke04YxNLs6WT4L_nznHbBTr66pPjOt-dP8ef7wh5Y53mSsMmB9YHmzIDnm6y2qRS5xbYCbhfEGMeHYvJCfsy5dOozemirHIRE0OgrmYOv5Hv5RBjgV3z8cf2MsWiUXi4Gito3CWbIXMZwFlOl_utMZOhkuS44HjYqVhMsZkVaq87371odxmWpEP9840lKQbmrdZ0MEl1X91iHf38V0X511FqWKEOH5IHkVrS_R4Lj8gd3zwm9_pik7-fkPYInBeCXVMh5tJwicVXFADkqf8V9bAN7W8Cd9Rcedqhuh3jIZ3PqDlF0p62ExouIX2gZzfE6BS4L7VYboJWMZ9n95ScHB58_zxJY72F1AHtmKdeOlFlFVMVE8ZVWpo8sxUm_FKMOaczw6WRtQgV03PvgapxYaW1RubWw472GdloZo1_QWhtZcFcBh0ayeBnsqLyRZ0X3CtTGJ6Q94spL11MRo41MX6W4VC8UGV3Xl60ZXxDCXm7NG_7LBy3Gb7D91eid0J_zsRLBjAqzHNV7o-V4kxoDpY7A0vwKjdoHg0QsHosBDRRCJ2Q7QUkyuj2XbkEKfS-plUwIMfAqWRCXi-b8cEodGv87LorheJSKy0SQm-xkFzjjXcJnTzvAbgaG9BHIVSeEDmA5tIAc4kPW5qzHyGneJFpxbmC-VuAeDXutTP98r__f5vc779Voa55h2zMr679K2BvczsKPjoim58Ojr9--wM4GEZ3 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rT9RAEN-QI0YTYnxbQdgPPr5Y6LX7NDEGFXIIdzEGEr4tu-0eQqRX6RHlj_J_dKaPO04Pv9GvM9lud2Z-O9udByEvXKq50nDIgf3BhcyCpdtoaEOpYwfeCZhfFYzZH4jeAft8yA8XyO82FwbDKltMrIA6G6X4j3wjBowF75p33xc_QmwahZerbQeNWit2_eVPOLGV73Y-gXhfxvH21v7HXtg0FQhT2FvHoZepyKKMqYwJm2Za2jhyGVa1UoylqY4sl1YORdUWPPYe_BEunHTOyth5jnUOAPEXGSa0dsjih63Bl6-Tawsmq96VXSCGDM5OTVHPKFEb5en6WbHOsAkeRlxf2QSbrWCpsCWIZVj305jn8P4bt_nX5W21J27fI3cbZ5Zu1tp3nyz4_AG5Vbe3vHxIij7ABcBrnqGWh1XajM8oqKyn_lcTgZvTOve4pPbc0xLj6RGB6XhE7TEeE8KiR6u0p7f05Er4OwVvmzpscEGzpoJo-Ygc3IgwHpNOPsr9U0KHTiYsjWBAKxk8NkoynwzjhHtlE8sD8qZdcpM25c-xC8d3U13DJ8qUp-asMI2EAvJqwl7UdT-uY3yN8jOIBzBeapu0BpgVVtYym12lOBOaA-fKDCfYcTpDXp3RgOlrAUJFInRAlluVMA3QlGZiFjD6HKpg4I6DFycDsjYh44sxtC73o4vSCMWlVloEhF7DIbnGHHsJgzypFXA6N3BYhVBxQOSMak4YsHr5LCU_-VZVMU8irThXsH6tEk_nPXeln_33-9fI7d5-f8_s7Qx2l8md-k8ZRlWvkM74_MI_B99x7FYbi6Xk6KZB4g8pn4L- |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIhASQrwJLa0PPC6km43fSAhVlNWW0ooDlfYWnMSBVjQbmq2gP41_x0ziZLuw5dZcPXIce-bz53gehDxLMyO0gUMO7A9pyC1Yuo0KGyoTp8BOwPwaZ8z9Azk-5B8mYrJCfnexMOhW2WFiA9T5NMN_5IMYMBbYtRgOCu8V8Wln9Lb6EWIBKbxo7apptBqy585_wumtfrO7A0v9PI5H7z-_G4e-wECYwT47C53KZB7lXOdc2iw3ysZRmmOGK815lpnICmVVIZsS4bFzwE2ETFWaWhWnTmDOA0D_a4oBqQJTUpP-rDfkqqliOWQCL1o19-k9I6YH9fHWSbXFsRwe-l5f2A79pnCrsjUsUNFW1lhGff_14PzrGrfZHUd3yG1Pa-l2q4d3yYor75HrbaHL8_uk2gfgAKAtc9T3sAmgcTkF5XXU_fK-uCVto5Brak8drdGzHrGYzqbUfsUDQ1iNaRMA9ZoeXXCEp8C7aYqlLmjuc4nWD8jhlSzFQ7JaTkv3mNAiVYxnEXRoFYfHRix3rIiZcNoyKwLyqpvyJPOJ0LEex_ekuZBnOqmPk5Mq8SsUkBe9eNVmALlM8CWuX4LIAP1l1gc4wKgwx1ayPdRacGkESK4vSIJFZwvNGwsaMH8tgKlk0gRkrVOJxENOnfQGAr0vaZUciDnwORWQzb4ZX4xOdqWbntWJ1EIZbWRA6CUSShiMtlfQyaNWAedjA-oqpY4DohZUsxfAPOaLLeXRtyafOYuMFkLD_HVKPB_30pl-8t_v3yQ3ABqSj7sHe2vkZvvLDN2r18nq7PTMPQUSOUs3GnOl5MtV48MfiwaFxQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mitochondrial-related+gene+expression+changes+are+sensitive+to+agonal-pH+state%3A+implications+for+brain+disorders&rft.jtitle=Molecular+psychiatry&rft.au=Vawter%2C+M+P&rft.au=Tomita%2C+H&rft.au=Meng%2C+F&rft.au=Bolstad%2C+B&rft.date=2006-07-01&rft.pub=Nature+Publishing+Group&rft.issn=1359-4184&rft.volume=11&rft.issue=7&rft.spage=663&rft_id=info:doi/10.1038%2Fsj.mp.4001830&rft.externalDocID=A188546950 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon |